SCHEMBL20127339

SCHEMBL20127339

c1ccc2c(c1)cc(-c1c3ccccc3c(-c3cc4oc5ccc6ccccc6c5c4c4ccccc34)c3ccccc13)c1ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.43
ALDH1A1 P00352 5/20 0.43
HPGD P15428 4/20 0.43
HIF1A Q16665 3/20 0.43
TSHR P16473 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
MAPK1 P28482 2/20 0.43
CASP1 P29466 1/20 0.43
CYP1B1 Q16678 1/20 0.42
AHR P35869 5/20 0.41
CYP1A2 P05177 4/20 0.41
FYN P06241 2/20 0.41
CYP1A1 P04798 1/20 0.41
MAPK3 P27361 1/20 0.41
PAX8 Q06710 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
HPRT1 P00492 1/20 0.41
MAPT P10636 2/20 0.40
MEN1 O00255 2/20 0.40
TP53 P04637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127707 0.92 AHR (0.42) HSD17B10HPGDTSHRL3MBTL1AHR
SCHEMBL20127722 0.92 ABCG2 (0.39) HSD17B10ALDH1A1HPGDHIF1ATSHR
SCHEMBL20127701 0.91 HPRT1 (0.42) HSD17B10ALDH1A1HPGDHIF1ATSHR
SCHEMBL20127711 0.90 TDP1 (0.41) HSD17B10ALDH1A1HPGDTSHRL3MBTL1
SCHEMBL22541859 0.89 HSD17B10 (0.44) HSD17B10ALDH1A1HPGDHIF1ATSHR
SCHEMBL20127709 0.89 SOS1 (0.49) HSD17B10ALDH1A1HPGDHIF1ATSHR
SCHEMBL20127732 0.89 AHR (0.40) HSD17B10ALDH1A1HPGDHIF1ATSHR
SCHEMBL20127704 0.88 ABCG2 (0.40) HSD17B10ALDH1A1HIF1AL3MBTL1CYP1B1
SCHEMBL18267009 0.87 AHR (0.43) HSD17B10ALDH1A1HPGDHIF1ATSHR
SCHEMBL20127705 0.86 ABCG2 (0.41) HSD17B10ALDH1A1HPGDHIF1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 HSD17B10 2025/4885ALDH1A1 476/4885HPGD 4205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.